原发性肝癌根治性切除术后复发按需治疗探讨  

A Study of Combined Treatment of TACE and PEI by Need in Recurrent Primary Liver Cancer (PLC) after Radical Resection

作　　者：干育红[1] 叶胜龙[1] 汤钊猷[1] 葛宁灵[1] 任正刚[1] 夏景林[1] 

机构地区：[1]复旦大学肝癌研究所,上海200032

出　　处：《中国临床医学》2002年第1期15-16,共2页Chinese Journal of Clinical Medicine

摘　　要：目的:探讨原发性肝癌根治性切除术后复发无手术指征者按需进行TACE和PEI治疗的优越性。方法:按需行TACE和PEI。结果:按需治疗者有较好的生存质量,不良反应较小,术后5年生存率达65.2％,与本研究所小肝癌根治性切除组5年生存率（64.8％）可比。结论:对原发性肝癌根治性切除术后复发无手术指征者按需行TACE和PEI治疗有助于提高生存质量,降低不良反应,延长生存期。: To investigate the advantage of combined treatment of TACE and PEI in the recurrent patients of PLC after radical resection. Methods: Forty-nine patients with recurrent PLC after radical resection were treated with both TACE and PEI by need and their survival rates were calculated by Kaplan-Miere method. Results: The survival rates of 1-, 3-and 5-year were 100% , 79.6% and 65.2% , respectively. All the patients have quite good life quality and lower side effects. Conclusion: Combination treatment by need with TACE and PEI is an effective and safe treatment modality that may prolong the survival of patients with recurrent PLC after radical resection.

关 键 词：原发性肝癌 复发 根治性切除术 TAC PET 按需治疗 手术后 

分 类 号：R735.7[医药卫生—肿瘤]